International Board of Directors Election

Meet the 2025 – 2026 Board

The ISPE International Board of Directors 2025 Election has concluded and the results are in. Below is the list of those members who have been elected to serve on the 2025-2026 Board of Directors.

The leadership transition between the 2024-2025 Board and the 2025-2026 Board will take place during the 2025 ISPE Annual Meeting & Expo, taking place in Charlotte, North Carolina, USA, and virtually from 26–29 October.

Executive Committee

Vivianne Arencibia
Vice President, Head of Quality Auditing and Risk Management
Lonza AG
Chair
Ylva Ek
Founder
Robur Life Science Advisory AB
Vice Chair
David Churchward
Head of Operations Quality Compliance and External Affairs
AstraZeneca
Treasurer
Georg Singewald
Global Head of Quality & Compliance
Roche / Genentech
Secretary
Jeffrey Biskup
Executive Chairman of the Board
CRB
Past Chair
Mike Martin
President and CEO
ISPE
Ex Officio Non-Voting Member

Re-Elected Director

Liz Dooley
Senior Director, Global Engineering & Technology
Johnson & Johnson

New Directors

Jose Caraballo
VP Quality Systems, Compliance, and Quality Engineering
Kite Pharma, Inc.
Victor Cruz
Sr. VP of Corporate Engineering and Global Health, Safety and Environmental
Eli LIlly & Company - Corporate Engineering
Francesco Intoccia
Senior Vice President Global Engineering Innovation
CSL Behring

Board Members Continuing a Term in 2025-2026

The following individuals will be continuing a two-year term in 2025-2026.

Norman Goldschmidt
President
Genesis AEC
James Grunwald
Senior Vice President US Business Development
Arcadis
Shanshan Liu
Technical Director
No Deviation Pte Ltd
Vivien Santillan
Regional Director, Asia
Novatek International

Board Members Completing Their Service

The following individuals will complete their Board service and will officially end their term at the 2025 ISPE Annual Meeting. ISPE thanks these individuals for their dedication and commitment to the organization.

Scott Billman
Senior Vice President Global Engineering, Technology, & Facilities
Solventum
Chair 2023 – 2024 & Immediate Past Chair
Sarah Pope Miksinski, PhD
Executive Director, CMC Regulatory Affairs
Gilead Sciences, Inc.
Timothy Watson
Vice President – Head of CMC Regulatory Affairs
Gilead Sciences

Candidate Nomination and Selection Process

Below are the steps taken for selecting candidates to be on the ballot:

  • Each year, the global membership of ISPE are asked to provide the names of potential candidates to the ISPE Nominating Committee. Candidates are proposed on the basis of a number of considerations communicated in the call for nominations including: strategic thinking, leadership skills, “business sense,” knowledge of the global pharma / biopharma industry, and the ability to commit the time and resources required to actively participate on the Board.
  • The Nominating Committee proposes a list of potential candidates for the vacancies on the Executive Committee and the International Board of Directors. The Board approves this list before the election.
  • Approved candidates are asked to confirm their willingness to stand for the election and to demonstrate that they have the support of their employer to serve.
  • Following the receipt of this information, the balloting process is arranged using an independent outside body, Intelliscan, Inc.

Intelliscan, Inc. conducts the entire election process and reports the results to the International Board of Directors.